Genentech’s Pulmozyme could also treat other respiratory infections and conditions
Category: News
The new technology can generate a target infection within 30 minutes to two hours
The most globally prevalent cancers include breast, lung, bowel and prostate cancers
Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK
The progressive neurodegenerative condition affects around 153,000 people in the UK
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
The awards celebrated both medical affairs and nursing professionals in the industry
The progressive neurodegenerative disease affects more than 55 million people globally
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally